These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Central and peripheral nervous system involvement in the L-tryptophan associated eosinophilia myalgia syndrome. Tolander LM; Bamford CR Int J Neurosci; 1991 Nov; 61(1-2):69-75. PubMed ID: 1809736 [TBL] [Abstract][Full Text] [Related]
7. Tryptophan and eosinophilia-myalgia syndrome. Hertzman PA; Brown RR West J Med; 1991 Feb; 154(2):229-30. PubMed ID: 1900976 [No Abstract] [Full Text] [Related]
8. Eosinophilia-myalgia syndrome and L-tryptophan. Golden RL N Y State J Med; 1990 Oct; 90(10):512-3. PubMed ID: 2234620 [No Abstract] [Full Text] [Related]
9. Clinical spectrum of eosinophilia-myalgia syndrome--California. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1990 Feb; 39(6):89-91. PubMed ID: 2105444 [No Abstract] [Full Text] [Related]
10. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751 [TBL] [Abstract][Full Text] [Related]
11. Update: analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1990 Nov; 39(43):789-90. PubMed ID: 2122210 [No Abstract] [Full Text] [Related]
12. A case of the eosinophilia-myalgia syndrome associated with use of an L-tryptophan product. Flannery MT; Wallach PM; Espinoza LR; Dohrenwend MP; Moscinski LC Ann Intern Med; 1990 Feb; 112(4):300-1. PubMed ID: 2297207 [No Abstract] [Full Text] [Related]
13. From the Centers for Disease Control. Analysis of L-tryptophan for etiology of eosinophilia-myalgia syndrome. JAMA; 1990 Nov; 264(20):2620. PubMed ID: 2232033 [No Abstract] [Full Text] [Related]
14. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. Slutsker L; Hoesly FC; Miller L; Williams LP; Watson JC; Fleming DW JAMA; 1990 Jul; 264(2):213-7. PubMed ID: 2355442 [TBL] [Abstract][Full Text] [Related]
15. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use. Varga J; Griffin R; Newman JH; Jimenez SA J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221 [TBL] [Abstract][Full Text] [Related]